CVKD
NASDAQ · Pharmaceuticals
Cadrenal Therapeutics Inc
$6.35
-0.32 (-4.80%)
Analyst Consensus
Strong Buy
7
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+166.9% upside
Low Target
$12.65
Average Target
$16.95
High Target
$22.59
Current Price
$6.35
Current
$6.35
$6.35
Target
$16.95
$16.95
$12.65
$16.95 avg
$22.59
Scenario Analysis
Bear Case
$12.65
99.2%
Low target
Base Case
$16.95
+166.9%
Avg target
Bull Case
$22.59
+255.7%
High target
Risk/Reward
2.6x
Favorable
Price in Context
52-Week High
$16.50
-61.5% from high
52-Week Low
$4.21
+50.8% from low
Target vs 52W High
$16.95
+2.7% vs high
Peer Consensus — Pharmaceuticals